Merck & Co., Inc. Faces Hundreds of Individual Fosamax Trials
Published: Sep 03, 2013
A federal judge overseeing consolidated litigation against Merck & Co over jaw injuries allegedly caused by the osteoporosis drug Fosamax has ordered hundreds of cases be dispersed to courts across the country for trial. The decision by U.S. District Judge John Keenan in Manhattan marks an unusual and potentially costly development for Merck. Companies often find it easier to reach settlements in mass tort cases that are consolidated before one judge.
Help employers find you! Check out all the jobs and post your resume.